CG
MDT icon

Carmignac Gestion’s Medtronic MDT Stock Holding History

Carmignac Gestion’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-486,813
Closed -$61M – 132
2021
Q3 		$61M Sell
486,813
-343,530
-41% -$44.5M 0.76% 37
2021
Q2 		$103M Sell
830,343
-683,861
-45% -$85.9M 1.2% 27
2021
Q1 		$179M Buy
1,514,204
+120,417
+9% +$14.1M 2.05% 17
2020
Q4 		$163M Buy
1,393,787
+223,924
+19% +$24.7M 1.71% 23
2020
Q3 		$122M Sell
1,169,863
-2,700
-0.2% -$271K 1.44% 26
2020
Q2 		$108M Buy
+1,172,563
New +$112M 1.49% 26
2019
Q3 		– Sell
-760,033
Closed -$74M – 134
2019
Q2 		$74M Sell
760,033
-740,199
-49% -$67.6M 0.92% 38
2019
Q1 		$137M Buy
+1,500,232
New +$134M 1.59% 29

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Carmignac Gestion's MDT Position: Q4 2021 in Review

Carmignac Gestion sold out of Medtronic (MDT) in Q4 2021, closing a stake of 486,813 shares — an estimated $61M sold.

Carmignac Gestion first reported a position in MDT in Q1 2019 and held it in 8 quarters. The position peaked at $179M in Q1 2021. 2,058 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Carmignac Gestion reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Carmignac Gestion sold 486,813 Medtronic shares in Q4 2021, an estimated $61M.
  • Carmignac Gestion first reported a position in Medtronic in Q1 2019 and held it in 8 quarters.
  • Carmignac Gestion's Medtronic position peaked at $179M in Q1 2021.
  • 2,058 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Carmignac Gestion's 13F filing for Q4 2021, filed 11 Feb 2022.